Poolbeg Pharma Plc

Poolbeg Pharma Plc company information, Employees & Contact Information

Poolbeg Pharma plc is a clinical-stage biopharmaceutical company focussed on the development of innovative medicines to address unmet medical needs. The Company’s clinical programmes target large addressable markets including, cancer immunotherapy-induced Cytokine Release Syndrome (“CRS”) and metabolic conditions such as obesity with the development of an oral encapsulated glucagon-like peptide GLP-1R agonist. Ticker AIM: POLB

Company Details

Employees
15
Founded
-
Address
40 Bank Street, Floor 24, London,e14 5nr,united Kingdom
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
London
Looking for a particular Poolbeg Pharma Plc employee's phone or email?

Poolbeg Pharma Plc Questions

News

Poolbeg Pharma kicks off POLB001 Phase 2a trial with specialist partner - Proactive financial news

Poolbeg Pharma kicks off POLB001 Phase 2a trial with specialist partner Proactive financial news

Poolbeg Pharma (AIM: POLB) Interim Results for the six months to 30 June 2025 - Share Talk

Poolbeg Pharma (AIM: POLB) Interim Results for the six months to 30 June 2025 Share Talk

Poolbeg Pharma plc (“Poolbeg” or the “Company”) Combination of Poolbeg and HOOKIPA Pharma Inc. - GlobeNewswire

Poolbeg Pharma plc (“Poolbeg” or the “Company”) Combination of Poolbeg and HOOKIPA Pharma Inc. GlobeNewswire

Poolbeg Pharma eyes ‘value-creating milestones’ with cancer therapy data set to emerge - The Irish Times

Poolbeg Pharma eyes ‘value-creating milestones’ with cancer therapy data set to emerge The Irish Times

Poolbeg Pharma PLC Announces Immunomodulator II Patent Granted in Japan - ACCESS Newswire

Poolbeg Pharma PLC Announces Immunomodulator II Patent Granted in Japan ACCESS Newswire

Poolbeg Pharma (AIM: POLB) POLB 001 Phase 2a Trial Update - Share Talk

Poolbeg Pharma (AIM: POLB) POLB 001 Phase 2a Trial Update Share Talk

AIM Market Roundup: Poolbeg Pharma, Caledonian, Jangada Mines - The Armchair Trader

AIM Market Roundup: Poolbeg Pharma, Caledonian, Jangada Mines The Armchair Trader

Poolbeg Pharma announces ‘milestone’ cancer therapy clinical trial agreement - Business Post

Poolbeg Pharma announces ‘milestone’ cancer therapy clinical trial agreement Business Post

SMALL CAP IDEA: Poolbeg Pharma raises £4.1m to finance cancer drugs - This is Money

SMALL CAP IDEA: Poolbeg Pharma raises £4.1m to finance cancer drugs This is Money

Poolbeg Pharma treatment gets FDA backing - The Irish Times

Poolbeg Pharma treatment gets FDA backing The Irish Times

Poolbeg Pharma Reports Strong Interim Results and Advances Key Clinical Trials - TipRanks

Poolbeg Pharma Reports Strong Interim Results and Advances Key Clinical Trials TipRanks

Poolbeg Pharma ‘laser-focused’ on cancer therapy drug after merger collapse - Business Post

Poolbeg Pharma ‘laser-focused’ on cancer therapy drug after merger collapse Business Post

Poolbeg Pharma CEO on active H1, POLB 001 & GLP-1 trial plans - Proactive financial news

Poolbeg Pharma CEO on active H1, POLB 001 & GLP-1 trial plans Proactive financial news

Poolbeg Pharma PLC (AIM:POLB) Director/PDMR Shareholding - Share Talk

Poolbeg Pharma PLC (AIM:POLB) Director/PDMR Shareholding Share Talk

Cathal Friel-chaired Poolbeg Pharma’s shares plunge on US tie-up talks - The Irish Times

Cathal Friel-chaired Poolbeg Pharma’s shares plunge on US tie-up talks The Irish Times

Poolbeg Pharma, Solvonis Therapeutics, EMV Capital, Light Science Technologies, Coinsilium Group - Proactive Investors

Poolbeg Pharma, Solvonis Therapeutics, EMV Capital, Light Science Technologies, Coinsilium Group Proactive Investors

Former Glen Dimplex boss acquires 5.74% stake in Poolbeg Pharma - Business Post

Former Glen Dimplex boss acquires 5.74% stake in Poolbeg Pharma Business Post

Poolbeg Pharma and Silk Road Therapeutics announce strategic collaboration on novel orphan drug - Proactive financial news

Poolbeg Pharma and Silk Road Therapeutics announce strategic collaboration on novel orphan drug Proactive financial news

Poolbeg Pharma (AIM:POLB) to Present at the H.C. Wainwright 26th Annual Global Investment Conference - Share Talk

Poolbeg Pharma (AIM:POLB) to Present at the H.C. Wainwright 26th Annual Global Investment Conference Share Talk

Poolbeg Pharma PLC Announces Influenza AI model build completed - ACCESS Newswire

Poolbeg Pharma PLC Announces Influenza AI model build completed ACCESS Newswire

Poolbeg Pharma, Polarean Imaging, Seeing Machines, Chariot, Valereum, Vaultz Capital - Proactive Investors

Poolbeg Pharma, Polarean Imaging, Seeing Machines, Chariot, Valereum, Vaultz Capital Proactive Investors

Poolbeg Pharma CEO on POLB001 & GLP-1 trial plans - ICYMI - Proactive Investors

Poolbeg Pharma CEO on POLB001 & GLP-1 trial plans - ICYMI Proactive Investors

Poolbeg Pharma shares rise on trial partnership - Proactive Investors

Poolbeg Pharma shares rise on trial partnership Proactive Investors

Roundup: PocDoc secures CE mark for lateral flow testing, Poolbeg Pharma and CytoReason partner, and more briefs - Mobi Health News

Roundup: PocDoc secures CE mark for lateral flow testing, Poolbeg Pharma and CytoReason partner, and more briefs Mobi Health News

Poolbeg Pharma shares rise 11% after US backs cancer therapy - Proactive Investors

Poolbeg Pharma shares rise 11% after US backs cancer therapy Proactive Investors

Poolbeg Pharma Insiders Lose Out As Stock Sinks To UK£0.077 - simplywall.st

Poolbeg Pharma Insiders Lose Out As Stock Sinks To UK£0.077 simplywall.st

Poolbeg Pharma gets FDA support for POLB 001 drug - RTE.ie

Poolbeg Pharma gets FDA support for POLB 001 drug RTE.ie

Poolbeg Pharma: New Capital, New Catalysts as POLB 001 Advances in the Clinic - Share Talk

Poolbeg Pharma: New Capital, New Catalysts as POLB 001 Advances in the Clinic Share Talk

Video: Poolbeg Pharma (POLB) Jeremy Skillington, CEO & Ian O’Connell , Chief Financial Officer - Shares Magazine

Video: Poolbeg Pharma (POLB) Jeremy Skillington, CEO & Ian O’Connell , Chief Financial Officer Shares Magazine

Poolbeg Pharma Plc (POLB) Share Price, RNS News And Interviews - DirectorsTalk Interviews

Poolbeg Pharma Plc (POLB) Share Price, RNS News And Interviews DirectorsTalk Interviews

Poolbeg Pharma secures FDA Orphan Drug Designation for POLB 001, shares jump - Vox Markets

Poolbeg Pharma secures FDA Orphan Drug Designation for POLB 001, shares jump Vox Markets

Poolbeg Pharma Immunomodulator II Patent Granted In Japan - DirectorsTalk Interviews

Poolbeg Pharma Immunomodulator II Patent Granted In Japan DirectorsTalk Interviews

Progress With Preventative Therapies at Poolbeg Pharma - businessplus.ie

Progress With Preventative Therapies at Poolbeg Pharma businessplus.ie

Poolbeg Pharma's Cathal Friel Assumes Role Of Executive Chairman - DirectorsTalk Interviews

Poolbeg Pharma's Cathal Friel Assumes Role Of Executive Chairman DirectorsTalk Interviews

Poolbeg Pharma ‘well-positioned to deliver’ for shareholders as it announces £10m cash balance - Business Post

Poolbeg Pharma ‘well-positioned to deliver’ for shareholders as it announces £10m cash balance Business Post

Glandore’s Michael Kelly increases his stake in Poolbeg Pharma - The Irish Times

Glandore’s Michael Kelly increases his stake in Poolbeg Pharma The Irish Times

Poolbeg Pharma H1 2024 results: POLB 001 on track with positive data and $10bn market opportunity - Vox Markets

Poolbeg Pharma H1 2024 results: POLB 001 on track with positive data and $10bn market opportunity Vox Markets

UK Stock Market News: Standard Chartered, Poolbeg Pharma, UK Oil & Gas - The Armchair Trader

UK Stock Market News: Standard Chartered, Poolbeg Pharma, UK Oil & Gas The Armchair Trader

Poolbeg Pharma to merge with Austrian biotech company - Irish Examiner

Poolbeg Pharma to merge with Austrian biotech company Irish Examiner

Poolbeg Pharma on a a new cancer immunity - Newstalk

Poolbeg Pharma on a a new cancer immunity Newstalk

Poolbeg Pharma agrees option agreement with UCD - The Irish Times

Poolbeg Pharma agrees option agreement with UCD The Irish Times

Our flu drug is not to be sniffed at, says Poolbeg Pharma chief Jeremy Skillington - The Times

Our flu drug is not to be sniffed at, says Poolbeg Pharma chief Jeremy Skillington The Times

Poolbeg Pharma shares jump on appointment of Cathal Friel as Executive Chairman - Vox Markets

Poolbeg Pharma shares jump on appointment of Cathal Friel as Executive Chairman Vox Markets

Open Orphan plc distribution in specie of Poolbeg Pharma plc shares – Q&A - Share Talk

Open Orphan plc distribution in specie of Poolbeg Pharma plc shares – Q&A Share Talk

Cathal Friel and Professor Luke O'Neill to host talk in Limerick - I Love Limerick

Cathal Friel and Professor Luke O'Neill to host talk in Limerick I Love Limerick

Poolbeg Pharma licenses oral delivery technology for treatment of diabetes and obesity - Vox Markets

Poolbeg Pharma licenses oral delivery technology for treatment of diabetes and obesity Vox Markets

Cathal Friel steps into the executive chair role at Poolbeg Pharma as leadership team beefed up - The Irish Independent

Cathal Friel steps into the executive chair role at Poolbeg Pharma as leadership team beefed up The Irish Independent

Poolbeg Pharma plc (POLB.L) Share Price, Updates & RNS News - Vox Markets

Poolbeg Pharma plc (POLB.L) Share Price, Updates & RNS News Vox Markets

Top Poolbeg Pharma Plc Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant